DNA Nanobots is a platform biotechnology company pioneering the use of functionalized DNA nanoparticles to address challenges associated with targeted delivery of therapeutic payloads. We specialize in engineering custom cell-targeted solutions for our partners to deliver drugs, nucleic acids, antibodies, and immunotherapies. We are also developing our own pipeline of therapeutics for cancer and rare diseases.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 01/24/24 | undisclosed | Pre-Seed | ||
| 12/17/25 | $3,500,000 | Seed |
